Numinus Wellness Inc
TSX:NUMI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CA |
|
Numinus Wellness Inc
XTSX:NUMI
|
106.6m CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
902.5B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581.1B USD |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.2B GBP |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.6B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
234.4B CHF |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.8B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.7B USD |
Loading...
|
Market Distribution
| Min | -9 940 586.9% |
| 30th Percentile | -85.9% |
| Median | -7.8% |
| 70th Percentile | 5.5% |
| Max | 60 777.6% |
Other Profitability Ratios
Numinus Wellness Inc
Glance View
Numinus Wellness, Inc. is a health care company that operates a testing and research facility that can support the emerging market of psychedelic therapies to supplement existing options in addressing mental illness, addictions, and post-traumatic stress disorder. The company is headquartered in Vancouver, British Columbia. The Company, through its subsidiary Salvation Botanicals Ltd, has a Health Canada cannabis testing license and dealer’s license. The testing license allows the Company to test and analyze cannabis products from licensed producers, and the dealer’s license allows the Company to test, possess, buy and sell methylenedioxymethamphetamine (MDMA), psilocybin, psilocin, dimethyltryptamine (DMT) and mescaline. Numinus also operates a stand-alone center offering patients integrative health solutions.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
Over the last 1 years, Numinus Wellness Inc’s Net Margin has increased from -1 698.4% to -1 104%. During this period, it reached a low of -1 698.4% on May 31, 2020 and a high of -1 104% on Jul 1, 2021.
